查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1986565

經導管主動脈瓣置換術市場：依手術方式、最終用戶和地區分類（2026-2034 年）

Transcatheter Aortic Valve Implantation Market by Procedure, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球經導管主動脈瓣置換術（TAVI）市場規模達77億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到191億美元，2026年至2034年的複合年成長率（CAGR）為9.72%。冠狀動脈疾病盛行率上升、微創治療的普及以及老年人口的成長是推動市場發展的主要因素。

經導管主動脈瓣置換術（TAVI）是一種微創手術，用於治療主動脈瓣狹窄。主動脈瓣狹窄是一種心臟疾病，患者主動脈瓣膜變窄，導致血液從心臟流向身體其他部位的流量減少。手術過程中，醫師會在患者鼠蹊部或胸部做一個小切口。然後，將導管插入患者體內，並經由股動脈或主動脈引導至狹窄的主動脈瓣膜。人工瓣膜由生物材料（例如動物組織）或合成材料製成，透過導管植入並放置在狹窄的瓣膜內。人工瓣膜會擴張並取代原有的瓣膜，從而恢復血液從心臟順暢流出。 TAVI 可在局部麻醉下進行。與傳統手術相比，TAVI 恢復期更短，併發症風險更低，因此適用於病情嚴重或身體虛弱而無法接受開胸手術的患者。

經導管主動脈瓣置換術（TAVI）市場趨勢：

心臟衰竭、高血壓、冠狀動脈疾病和心血管疾病（CVD，尤其是主動脈瓣狹窄）患者數量的不斷增加，是經導管主動脈瓣置換術（TAVI）市場成長的主要驅動力。此外，由於微創手術（MIS）具有住院時間短、恢復時間短、治療效果好、整體醫療成本低等優勢，患者越來越傾向於選擇微創手術而非傳統開胸手術，這為市場帶來了良好的前景。同時，患者對主動脈瓣疾病及其治療方法的認知度不斷提高，使得早期診斷和及時治療成為可能，這也促進了市場成長。此外，對研發的大量投入以及TAVI手術技術的持續進步，包括生物瓣膜、自膨式瓣膜和其他創新裝置的研發，都在推動市場成長。最後，醫療產業的強勁成長、臨床試驗的增加、產品的持續創新、老年人口的成長以及有利的健保政策，都為市場創造了盈利的成長機會。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章：引言

第5章：全球經導管主動脈瓣置換術（TAVI）市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場細分：依技術分類

  • 股動脈路徑
  • 從根尖植入
  • 經主動脈植入

第7章 市場區隔：依最終用戶分類

  • 醫院
  • 診斷檢查室
  • 門診手術中心
  • 診所
  • 其他

第8章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第9章 促進因素、阻礙因素和機遇

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Edwards Lifesciences Corporation
    • JC Medical Inc.（Genesis Medtech International Private Limited）
    • Medtronic plc
    • Meril Life Sciences Pvt. Ltd.
    • NVT AG（Biosensors International Group）
    • Venus Medtech（Hangzhou）Inc.
Product Code: SR112026A7501

The global transcatheter aortic valve implantation (TAVI) market size reached USD 7.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 19.1 Billion by 2034, exhibiting a growth rate (CAGR) of 9.72% during 2026-2034. The increasing prevalence of coronary artery disease, the rising adoption of minimally invasive therapies, and the expanding geriatric population represent some of the key factors driving the market.

Transcatheter Aortic Valve Implantation (TAVI) refers to a minimally invasive surgical procedure used to treat aortic stenosis, a heart condition in which the aortic valve narrows, resulting in reduced blood flow from the heart to the rest of the body. During the procedure, a small incision is made in the patient's groin or chest. A catheter is inserted and guided through the femoral artery or the aorta to the narrowed aortic valve. An artificial valve made of biological material, such as animal tissue or synthetic materials, is deployed through the catheter and positioned inside the narrowed valve, which expands to replace the old valve, allowing blood to flow freely from the heart. TAVI can be performed under local anesthesia. Compared to traditional surgery, it has a shorter recovery time and a lower risk of complications and can be performed on patients who are too ill or frail to undergo open-heart surgery.

TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) MARKET TRENDS:

The growing number of patients suffering from heart failure, hypertension, coronary artery disease, and cardiovascular diseases (CVDs), particularly aortic stenosis, is primarily driving the transcatheter aortic valve implantation (TAVI) market growth. Besides this, the shifting consumer preference for minimally invasive surgery (MIS) over conventional open-heart surgery due to its advantages, such as reduced hospital stay, shorter recovery time, improved outcomes, and lower overall healthcare spending, is creating a positive outlook for the market. Moreover, the escalating consumer awareness about aortic valve disease and available treatment options leading to early diagnosis and timely treatment is contributing to the market growth. In addition to this, the extensive funding in research and development (R&D) initiatives and ongoing technological advancements in the TAVI procedure, such as the development of bioprosthetic valves, self-expanding valves, and other innovative devices, are strengthening the market growth. Furthermore, the bolstering growth of the healthcare industry, the increasing number of clinical trials, continuous product innovations, the expanding geriatric population, and favorable reimbursement policies are presenting remunerative growth opportunities for the market.

KEY MARKET SEGMENTATION:

Procedure Insights:

  • Transfemoral Procedure
  • Transapical Implantation
  • Transaortic Implantation

End User Insights:

  • Hospitals
  • Diagnostic Labs
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for transcatheter aortic valve implantation (TAVI). Some of the factors driving the North America transcatheter aortic valve implantation (TAVI) market included the expanding prevalence of cardiovascular diseases, the rising adoption of minimally invasive therapies, and ongoing technological advancements.

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global transcatheter aortic valve implantation (TAVI) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, JC Medical Inc. (Genesis Medtech International Private Limited), Medtronic plc, Meril Life Sciences Pvt. Ltd., NVT AG (Biosensors International Group), Venus Medtech (Hangzhou) Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the global transcatheter aortic valve implantation (TAVI) market?

2. What is the expected growth rate of the global transcatheter aortic valve implantation (TAVI) market during 2026-2034?

3. What are the key factors driving the global transcatheter aortic valve implantation (TAVI) market?

4. What has been the impact of COVID-19 on the global transcatheter aortic valve implantation (TAVI) market?

5. What is the breakup of the global transcatheter aortic valve implantation (TAVI) market based on the procedure?

6. What is the breakup of the global transcatheter aortic valve implantation (TAVI) market based on the end user?

7. What are the key regions in the global transcatheter aortic valve implantation (TAVI) market?

8. Who are the key players/companies in the global transcatheter aortic valve implantation (TAVI) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transcatheter Aortic Valve Implantation (TAVI) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Procedure

  • 6.1 Transfemoral Procedure
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Transapical Implantation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Transaortic Implantation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostic Labs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ambulatory Surgical Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Clinics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Boston Scientific Corporation
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Edwards Lifesciences Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 JC Medical Inc. (Genesis Medtech International Private Limited)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 Medtronic plc
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Meril Life Sciences Pvt. Ltd.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 NVT AG (Biosensors International Group)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Venus Medtech (Hangzhou) Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials

List of Figures

  • Figure 1: Global: Transcatheter Aortic Valve Implantation Market: Major Drivers and Challenges
  • Figure 2: Global: Transcatheter Aortic Valve Implantation Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Transcatheter Aortic Valve Implantation Market: Breakup by Procedure (in %), 2025
  • Figure 5: Global: Transcatheter Aortic Valve Implantation Market: Breakup by End User (in %), 2025
  • Figure 6: Global: Transcatheter Aortic Valve Implantation Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Transcatheter Aortic Valve Implantation (Transfemoral Procedure) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Transcatheter Aortic Valve Implantation (Transfemoral Procedure) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Transcatheter Aortic Valve Implantation (Transapical Implantation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Transcatheter Aortic Valve Implantation (Transapical Implantation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Transcatheter Aortic Valve Implantation (Transaortic Implantation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Transcatheter Aortic Valve Implantation (Transaortic Implantation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Transcatheter Aortic Valve Implantation (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Transcatheter Aortic Valve Implantation (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Transcatheter Aortic Valve Implantation (Diagnostic Labs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Transcatheter Aortic Valve Implantation (Diagnostic Labs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Transcatheter Aortic Valve Implantation (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Transcatheter Aortic Valve Implantation (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Transcatheter Aortic Valve Implantation (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Transcatheter Aortic Valve Implantation (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Transcatheter Aortic Valve Implantation (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Transcatheter Aortic Valve Implantation (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: North America: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: North America: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: United States: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: United States: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Canada: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Canada: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Asia-Pacific: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Asia-Pacific: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: China: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: China: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Japan: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Japan: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: India: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: India: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: South Korea: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: South Korea: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Australia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Australia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Indonesia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Indonesia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Europe: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Europe: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Germany: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Germany: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: France: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: France: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: United Kingdom: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: United Kingdom: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Italy: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Italy: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Spain: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Spain: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Russia: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Russia: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Latin America: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Latin America: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Brazil: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Brazil: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Mexico: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Mexico: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Middle East and Africa: Transcatheter Aortic Valve Implantation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Middle East and Africa: Transcatheter Aortic Valve Implantation Market: Breakup by Country (in %), 2025
  • Figure 71: Middle East and Africa: Transcatheter Aortic Valve Implantation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Global: Transcatheter Aortic Valve Implantation Industry: Drivers, Restraints, and Opportunities
  • Figure 73: Global: Transcatheter Aortic Valve Implantation Industry: Value Chain Analysis
  • Figure 74: Global: Transcatheter Aortic Valve Implantation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transcatheter Aortic Valve Implantation Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by Procedure (in Million USD), 2026-2034
  • Table 3: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 4: Global: Transcatheter Aortic Valve Implantation Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Transcatheter Aortic Valve Implantation Market: Competitive Structure
  • Table 6: Global: Transcatheter Aortic Valve Implantation Market: Key Players